Advertisement
Screener

Quanterix Corporation (QTRX) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

Quanterix Corporation Increase (Decrease) in Accounts Receivable

Quanterix Corporation (QTRX) reported Increase (Decrease) in Accounts Receivable of -$6.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-10

  • Quanterix Corporation increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$4.10M.
  • Quanterix Corporation increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$2.72M.
  • Quanterix Corporation increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$2.71M, a 307.99% decline year-over-year.
  • Quanterix Corporation increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $1.57M.
  • Quanterix Corporation increase (decrease) in accounts receivable for fiscal 2025 was -$10.61M, a 237.71% decline from fiscal 2024.
  • Quanterix Corporation increase (decrease) in accounts receivable for fiscal 2024 was $7.70M, a 15.07% increase from fiscal 2023.
  • Quanterix Corporation increase (decrease) in accounts receivable for fiscal 2023 was $6.70M.
  • Quanterix Corporation increase (decrease) in accounts receivable for fiscal 2022 was -$5.16M, a 175.24% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 3 month as first filedIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 12 monthIncrease (Decrease) in Accounts Receivable 12 month as first filed
2026-06-30-$4.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$6.82M
10-Q · filed 2026-08-10
-$9.53M
derived: sum of 3 quarters · filed 2026-08-10
-$7.95M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31-$2.72M
10-Q · filed 2026-05-06
-$5.42M
derived: sum of 2 quarters · filed 2026-05-06
-$3.85M
derived: sum of 3 quarters · filed 2026-05-06
-$9.00M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31-$2.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$1.13M
derived: sum of 2 quarters · filed 2026-03-02
-$6.28M
derived: sum of 3 quarters · filed 2026-08-10
-$10.61M
10-K · filed 2026-03-02
2025-09-30$1.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$3.57M
derived: sum of 2 quarters · filed 2026-08-10
-$7.90M
10-Q · filed 2025-11-10
-$6.60M
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30-$5.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$9.48M
10-Q · filed 2026-08-10
-$8.17M
derived: sum of 3 quarters · filed 2026-08-10
-$9.01M
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31-$4.33M
10-Q · filed 2026-05-06
-$3.03M
derived: sum of 2 quarters · filed 2026-05-06
-$3.87M
derived: sum of 3 quarters · filed 2026-05-06
-$755.00K
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$1.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$462.00K
derived: sum of 2 quarters · filed 2026-03-02
$3.57M
derived: sum of 3 quarters · filed 2026-03-02
$7.70M
10-K · filed 2026-03-02
2024-09-30-$840.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$2.27M
derived: sum of 2 quarters · filed 2025-11-10
$6.40M
10-Q · filed 2025-11-10
$7.48M
derived: sum of 4 quarters · filed 2026-03-02
2024-06-30$3.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$7.24M
10-Q · filed 2025-08-07
$8.32M
derived: sum of 3 quarters · filed 2026-03-02
$8.19M
derived: sum of 4 quarters · filed 2026-03-02
2024-03-31$4.13M
10-Q · filed 2025-05-12
$4.23M
10-Q · filed 2024-05-08
$5.21M
derived: sum of 2 quarters · filed 2026-03-02
$5.08M
derived: sum of 3 quarters · filed 2026-03-02
$7.08M
derived: sum of 4 quarters · filed 2026-03-02
2023-12-31$1.08M
derived: 10-K 12 month − 10-K/A 9 month · filed 2026-03-02
$945.00K
derived: sum of 2 quarters · filed 2026-03-02
$2.95M
derived: sum of 3 quarters · filed 2026-03-02
$6.70M
10-K · filed 2026-03-02
2023-09-30-$135.00K
derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-12-26
$1.87M
derived: sum of 2 quarters · filed 2024-12-26
$5.62M
10-K/A · filed 2024-12-26
$5.50M
derived: sum of 4 quarters · filed 2025-03-17
2023-06-30$2.01M
derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-12-26
$5.75M
10-K/A · filed 2024-12-26
$5.64M
derived: sum of 3 quarters · filed 2025-03-17
$4.07M
derived: sum of 4 quarters · filed 2025-03-17
2023-03-31$3.74M
10-K/A · filed 2024-12-26
$3.67M
10-Q · filed 2023-05-09
$3.63M
derived: sum of 2 quarters · filed 2025-03-17
$2.06M
derived: sum of 3 quarters · filed 2025-03-17
-$96.00K
derived: sum of 4 quarters · filed 2025-03-17
2022-12-31-$111.00K
derived: 10-K 12 month − 10-K/A 9 month · filed 2025-03-17
-$1.68M
derived: sum of 2 quarters · filed 2025-03-17
-$3.84M
derived: sum of 3 quarters · filed 2025-03-17
-$5.16M
10-K · filed 2025-03-17
2022-09-30-$1.57M
derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-12-26
-$3.73M
derived: sum of 2 quarters · filed 2024-12-26
-$5.04M
10-K/A · filed 2024-12-26
$252.00K
derived: sum of 4 quarters · filed 2024-12-26
2022-06-30-$2.16M
derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-12-26
-$3.48M
10-K/A · filed 2024-12-26
$1.82M
derived: sum of 3 quarters · filed 2024-12-26
$5.11M
derived: sum of 4 quarters · filed 2024-12-26
2022-03-31-$1.32M
10-K/A · filed 2024-12-26
$3.98M
derived: sum of 2 quarters · filed 2024-12-26
$7.27M
derived: sum of 3 quarters · filed 2024-12-26
$7.76M
derived: sum of 4 quarters · filed 2024-12-26
2021-12-31$5.30M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26
$8.59M
derived: sum of 2 quarters · filed 2024-12-26
$9.08M
derived: sum of 3 quarters · filed 2024-12-26
$6.85M
10-K/A · filed 2024-12-26
2021-09-30$3.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$3.78M
derived: sum of 2 quarters · filed 2022-11-09
$1.56M
10-Q · filed 2022-11-09
-$7.07M
derived: sum of 4 quarters · filed 2023-03-06
2021-06-30$487.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$1.74M
10-Q · filed 2022-08-08
-$10.37M
derived: sum of 3 quarters · filed 2023-03-06
$6.44M
derived: sum of 4 quarters · filed 2023-03-06
2021-03-31-$2.23M
10-Q · filed 2022-05-10
-$10.85M
derived: sum of 2 quarters · filed 2023-03-06
$5.95M
derived: sum of 3 quarters · filed 2023-03-06
$3.33M
derived: sum of 4 quarters · filed 2023-03-06
2020-12-31-$8.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
$8.18M
derived: sum of 2 quarters · filed 2023-03-06
$5.56M
derived: sum of 3 quarters · filed 2023-03-06
$6.73M
10-K · filed 2023-03-06
$6.24M
10-K · filed 2021-03-05
2020-09-30$16.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$14.19M
derived: sum of 2 quarters · filed 2021-11-04
$15.36M
10-Q · filed 2021-11-04
$14.41M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$2.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$1.45M
10-Q · filed 2021-08-05
-$2.39M
derived: sum of 3 quarters · filed 2022-03-01
-$216.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$1.17M
10-Q · filed 2021-05-06
$225.00K
derived: sum of 2 quarters · filed 2022-03-01
$2.40M
derived: sum of 3 quarters · filed 2022-03-01
$4.23M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$949.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$1.23M
derived: sum of 2 quarters · filed 2022-03-01
$3.06M
derived: sum of 3 quarters · filed 2022-03-01
$3.52M
10-K · filed 2022-03-01
$3.37M
10-K · filed 2020-03-13
2019-09-30$2.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$4.01M
derived: sum of 2 quarters · filed 2020-11-06
$4.47M
10-Q · filed 2020-11-06
$6.62M
derived: sum of 4 quarters · filed 2021-03-05
2019-06-30$1.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
$2.30M
10-Q · filed 2020-08-04
$4.44M
derived: sum of 3 quarters · filed 2021-03-05
$5.50M
derived: sum of 4 quarters · filed 2021-03-05
2019-03-31$465.00K
10-Q · filed 2020-05-07
$2.61M
derived: sum of 2 quarters · filed 2021-03-05
$3.67M
derived: sum of 3 quarters · filed 2021-03-05
$2.60M
derived: sum of 4 quarters · filed 2021-03-05
2018-12-31$2.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05
$3.21M
derived: sum of 2 quarters · filed 2021-03-05
$2.13M
derived: sum of 3 quarters · filed 2021-03-05
$983.00K
10-K · filed 2021-03-05
2018-09-30$1.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$12.00K
derived: sum of 2 quarters · filed 2019-11-08
-$1.16M
10-Q · filed 2019-11-08
$235.00K
derived: sum of 4 quarters · filed 2020-03-13
2018-06-30-$1.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$2.22M
10-Q · filed 2019-08-06
-$828.00K
derived: sum of 3 quarters · filed 2020-03-13
$250.00K
derived: sum of 4 quarters · filed 2020-03-13
2018-03-31-$1.15M
10-Q · filed 2019-05-10
$247.00K
derived: sum of 2 quarters · filed 2020-03-13
$1.32M
derived: sum of 3 quarters · filed 2020-03-13
$798.00K
derived: sum of 4 quarters · filed 2020-03-13
2017-12-31$1.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$2.47M
derived: sum of 2 quarters · filed 2020-03-13
$1.95M
derived: sum of 3 quarters · filed 2020-03-13
$1.68M
10-K · filed 2020-03-13
2017-09-30$1.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$551.00K
derived: sum of 2 quarters · filed 2018-11-07
$287.00K
10-Q · filed 2018-11-07
2017-06-30-$527.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10
-$791.00K
10-Q · filed 2018-08-10
2017-03-31-$264.00K
10-Q · filed 2018-05-15
2016-12-31$1.66M
10-K · filed 2019-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15